Nigeria faces a potential crisis in healthcare delivery unless urgent measures are taken to strengthen and integrate supply chains, according to Mercy Itopa, a Nigerian pharmacist and health systems strategist. In a recent paper obtained by this medium, Itopa highlighted vulnerabilities in Nigeria’s public health infrastructure that were exposed during the COVID-19 pandemic and warned that failure to address them could compromise treatment continuity for millions of patients.

“COVID-19 did not just challenge supply chains, it exposed their fragility,” Itopa wrote. “The next pandemic will not forgive us if we do not fix what was revealed.” Her analysis identifies overreliance on foreign manufacturing hubs, fragile maritime security, and weak data systems as the primary risks undermining the resilience of Nigeria’s healthcare supply chains. During the pandemic, she noted, these weaknesses left hospitals and clinics scrambling for essential medicines, personal protective equipment, and HIV and tuberculosis treatments when borders closed.

Contrasting Nigeria’s experience with that of the United States, Itopa observed that robust local production, predictive logistics models, and real-time digital monitoring enabled U.S. facilities to respond more efficiently. In Nigeria, by contrast, basic stock visibility was lacking, leaving facilities unable to anticipate shortages. Drawing on her experience with APIN Public Health Initiatives, she described emergency measures such as multi-month dispensing of HIV drugs as necessary stopgaps, but not sustainable solutions.

Her training in the United States, which includes a Master of Health Administration and a Graduate Certificate in Health Data Analytics, informs her recommendations. “Real-time data kept hospitals one step ahead,” she explained. “In Nigeria, the absence of such systems left us three steps behind.” She further cautioned against overdependence on foreign aid, noting that donor support, while crucial during COVID-19, is unreliable when global crises shift attention elsewhere.

Itopa emphasised that pharmacy expertise must be incorporated into strategic planning. “Supply chains are not neutral,” she said. “They require technical knowledge to forecast demand and prevent shortages. Excluding pharmacists from administrative decision-making is a mistake that costs lives.”

Among her recommendations are the establishment of regional supply hubs within Africa, harmonisation of trade regulations, reinforcement of maritime security, and investment in digital infrastructure to track stock from central warehouses to rural clinics. She argued that these measures are vital to ensure uninterrupted care and safeguard public health against future emergencies.

Her warnings align with recent assessments by the World Health Organisation and the African Union, both of which have identified weak supply chains as the greatest obstacle to achieving universal health coverage in Africa. Itopa concluded that systemic reform and local capacity-building are essential if Nigeria is to avoid repeating the disruptions witnessed during the pandemic.